1,515% 26.66

Second Sight Medical Products, (EYES)

개요 뉴스 가격 이력 토론 예측

Relative Volume:

Second Sight Medical Products, Stock (EYES) Company Profile

Second Sight Medical Products,

Healthcare (1065)

Medical Devices (140)

818-833-5000

12744 San Fernando Road, Suite 400, Sylmar

최신 SEC 제출 서류

EYES's Discussions on Twitter

Compare EYES vs ABT, MDT, SYK, BSX, EW

주식	가격	시가총액	매출	순이익	현금흐름	주당 순 이익
EYES Second Sight Medical Products,	28.42	0	0	0	0	0.00
ABT Abbott Laboratories	102.61	176.41B	46.59B	5.41B	7.38B	3.0938
MDT Medtronic Plc	92.13	116.35B	36.36B	4.84B	5.43B	3.7261
SYK Stryker Corp	275.12	105.70B	25.27B	3.34B	4.57B	8.6334
BSX Boston Scientific Corp	43.34	62.29B	20.62B	3.56B	3.48B	2.3847
EW Edwards Lifesciences Corp	88.26	48.63B	6.30B	1.07B	1.09B	1.8406

Second Sight Medical Products, Stock (EYES) Upgrades & Downgrades

날짜	액션	분석자	등급 변경
2019-12-13	개시	Dougherty & Company	Buy
2015-07-06	개시	H.C. Wainwright	Buy

Second Sight Medical Products, 주식(EYES)의 최신 뉴스

Second Sight Medical Products, (EYES) 재무 분석

Second Sight Medical Products, (EYES)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.

Second Sight Medical Products, (EYES)

Second Sight Medical Products, Stock (EYES) Company Profile

Compare EYES vs ABT, MDT, SYK, BSX, EW

Second Sight Medical Products, Stock (EYES) Upgrades & Downgrades

Second Sight Medical Products, 주식(EYES)의 최신 뉴스

Second Sight Medical Products Inc (VANIW) Key Financial Ratios – Valuation, Profitability & More - Value Research

Second Sight Medical Products Inc (VANIW) Peer Comparison – Compare with Others - Value Research

Second Sight Medical Products Inc. Warrants (EYESW) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Second Sight Medical Products Inc. Warrants (EYESW) Financials – Balance Sheet, Profit & Loss, Cash Flow - valueresearchonline.com

Second Sight Medical Products Inc. Warrants (EYESW) Key Financial Ratios – Valuation, Profitability & More - valueresearchonline.com

Second Sight Medical Products Inc. (EYES) Peer Comparison – Compare with Others - Value Research

Second Sight Medical Products Inc (VANIW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research

Second Sight Medical Products Inc (VANIW) Shareholding Pattern – Promoters, FIIs & DIIs - valueresearchonline.com

Vivani Medical Reports Second Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire

EU Clears PRIMA Retinal Chip for Commercial Sale After AMD Patient Reads 300-Page Novel - The Eastern Herald

Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live stream - GlobeNewswire Inc.

ClearOne skyrockets from neurotech pivot, merger with Cortigent - Mugglehead Investment Magazine

Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - markets.businessinsider.com

Vivani Medical allows Novo Nordisk to evaluate NPM-139 - scanx.trade

ClearOne Merging With Cortigent - Pulse 2.0

Vivani to sell neurotech subsidiary Cortigent to ClearOne - MassDevice

ClearOne Announces Entry into Merger Agreement with Cortigent, Inc., a Wholly-Owned Subsidiary of Vivani Medical - Business Wire

Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker - GlobeNewswire

Vivani Medical appoints August Moretti to board as Dr. Dean Baker retires - scanx.trade

Vivani Medical CEO Adam Mendelsohn to Present at the 2026 BIO International Convention - markets.businessinsider.com

European Union Retinal Implant Electrode ArraysMarket Analysis, Forecast, Size, Trends and Insights - IndexBox

World Auditory Brainstem ImplantsMarket Analysis, Forecast, Size, Trends and Insights - IndexBox

Visual Prosthesis Market Size, Share, Growth, Forecast, 2034 - Straits Research

Vivani Medical CEO Adam Mendelsohn to Present at the Jefferies Global Healthcare Conference on June 4, 2026 - markets.businessinsider.com

Vivani Medical Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire

Medical Bionic Implant and Artificial Organs Price in the European UnionMarket Insights - IndexBox

Stock List: Research Stocks from Around the World - GuruFocus

Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewswire

Single semaglutide implant showed >20% weight loss for a year - Stock Titan

Promising Six-Year Early Feasibility Study Results Released for the Orion System - Medical Product Outsourcing

Electroceuticals Market Size, Share & Growth Report, 2034 - Market Data Forecast

'Bionic Eye' Helps Man See After Decade of Impaired VisionABC News - ABC News - Breaking News, Latest News and Videos

Don’t Let Elon Musk Implant a Device in Your Skull - Home ❧ Current Affairs

Vivani Subsidiary Cortigent Presents Promising 6-Year Early - GlobeNewswire

Vivani Subsidiary Cortigent to Present Orion System’s - GlobeNewswire

Artificial Eye Market Size, Share, Growth | CAGR of 7.8% - Market.us

Study Links Rod Cell Evolution to Dinosaur Extinction Event - 동아사이언스

Robert Greenberg Net WorthInsider Trades and Bio as of Apr 22, 2026 - Benzinga

Science Corp.'s Prima implant enables blind patients to read - bioworld.com

Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off - GlobeNewswire

Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders - GlobeNewswire

Ocular Implants Market Size, Demand & Revenue Statistics by 2033 - Straits Research

Vivani Medical Appoints Anthony Baldor as Chief Financial Officer - GlobeNewswire

EYES Stock Price, News & Analysis - Stock Titan

Vivani to spin off neurostimulation business - MedTech Dive

Vivani Medical Announces Intent to Spin Off Cortigent Neurostimulation Business - Business Wire

Sight Care – Study Findings, Reviews, Ingredients and Where to Buy It - GlobeNewswire

Cortigent, Inc IPOs Tomorrow, Here's What You Need To Know - Sahm

Second Sight Medical’s Argus II Recognized by Popular Science Magazine - Medical Product Outsourcing

Bionic Eye Market to Reach US$ 524 Million by 2032 - Market.us Media

Treatment and technology: The future of retina care - Ophthalmology Times Europe

Second Sight Medical Products, (EYES) 재무 분석

매출

순이익

현금흐름

주당 순 이익

EYES과 유사한 종목